On the other hand, a decreased serum clusterin level has been proven during osteoarthritis [59], systemic lupus erythematosus [60], sepsis [61], human hepatocellular carcinoma [62], and esophageal squamous cell carcinoma [63]. This evidence concerns the gene CLU and hepatocellular carcinoma.